ACTINIUM PHARMACEUTICALS, INC. Interest Payable, Current
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Interest Payable, Current of $24.84 thousand as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2011-11-14
- 2011-09-30: Interest Payable, Current $24.84K.
- 2011-06-30: Interest Payable, Current $23.75K.
- 2010-12-31: Interest Payable, Current $21.25K.
| Period end | Interest Payable, Current |
|---|---|
| 2011-09-30 | $24.84K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $23.75K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $21.25K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |